The National Institute of Drug Abuse (NIDA) is offering this grant to enhance understanding of epigenomic processes and non-coding RNAs in HIV infection and pathogenesis, particularly in combination with substance abuse. This NIH Exploratory/Developmental Research Grant (R21) aims to stimulate innovative research, foster new approaches, and encourage collaborations among experts in HIV/AIDS, drug abuse, and epigenomics. This grant is for researchers proposing studies that delve into the complex interplay between epigenomics, HIV, and substance abuse, facilitating new discoveries. A total of $2.5 million is allocated across this R21 FOA (RFA-DA-10-011) and a companion R01, with an anticipated funding of 4-6 R21 awards.
Opportunity ID: 49332
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-DA-10-011 |
Funding Opportunity Title: | Exploring Epigenomic Processes and Non-Coding RNAs in HIV/AIDS (R21) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Education Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Sep 03, 2009 |
Last Updated Date: | – |
Original Closing Date for Applications: | Dec 23, 2009 |
Current Closing Date for Applications: | Dec 23, 2009 |
Archive Date: | Jan 23, 2010 |
Estimated Total Program Funding: | $2,500,000 |
Award Ceiling: | $200,000 |
Award Floor: | – |
Eligibility
Eligible Applicants: | Native American tribal governments (Federally recognized) Special district governments Public and State controlled institutions of higher education County governments City or township governments State governments Private institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) For profit organizations other than small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities Small businesses Independent school districts Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | Purpose. The purpose of this FOA issued by the National Institute of Drug Abuse, National Institutes of Health, is to enhance our understanding of the role of epigenomics in HIV infection and pathogenesis in combination with substance abuse. This FOA invites applications proposing innovative research to stimulate new areas of research or develop new approaches to existing studies. Newly-formed collaborations to foster sharing of expertise between the fields of HIV/AIDS, drug abuse, and epigenomics research are encouraged. Mechanism of Support. This FOA will utilize the NIH Exploratory/Developmental Research Grant (R21) award mechanism and runs in parallel with a FOA of identical scientific scope, RFA-DA-10-010, that solicits applications under the Research Project Grant (R01) mechanism. Funds Available and Anticipated Number of Awards. A total of $2.5 million has been set aside for this R21 FOA (RFA-DA-10-011) and the companion R01 FOA (RFA-DA-10-010). It is anticipated that 2-4 R01s and 4-6 R21s could be funded. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-10-011.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
93.279 | ADOBE-FORMS-A | Adobe-Forms-A | PKG00013865 | Nov 23, 2009 | Dec 23, 2009 | View |
Package 1
Mandatory forms
49332 RR_SF424-1.1.pdf
49332 RR_KeyPersonExpanded-1.1.pdf
49332 RR_OtherProjectInfo-1.1.pdf
49332 RR_PerformanceSite-1.1.pdf
49332 PHS398_CoverPageSupplement-1.1.pdf
49332 PHS398_ResearchPlan-1.1.pdf
49332 PHS398_Checklist-1.1.pdf
Optional forms
49332 PHS398_CoverLetter-1.1.pdf
49332 PHS398_ModularBudget-1.1.pdf
49332 RR_Budget-1.1.pdf
49332 RR_SubawardBudget-1.2.pdf